181 related articles for article (PubMed ID: 14586902)
41. [Viral quasispecies and their implications in antiviral therapy].
Fernández B; Basaras M; Blanco S; Sánchez S; Arrese E; de las Heras B; Cisterna R
Rev Esp Quimioter; 2002 Mar; 15(1):49-54. PubMed ID: 12582437
[TBL] [Abstract][Full Text] [Related]
42. Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.
Mazzaferro V; Regalia E; Pulvirenti A; Tagger A; Andreola S; Pasquali M; Baratti D; Romano F; Palazzo U; Zuin M; Bonino F; Ribero ML; Gennari L
Transplant Proc; 1997; 29(1-2):519-21. PubMed ID: 9123113
[No Abstract] [Full Text] [Related]
43. Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency.
Razvi S; Schneider L; Jonas MM; Cunningham-Rundles C
Clin Immunol; 2001 Dec; 101(3):284-8. PubMed ID: 11726220
[TBL] [Abstract][Full Text] [Related]
44. Is it now the time to update treatment protocols for lymphomas with new anti-virus systems?
Luppi M; Barozzi P; Potenza L; Riva G; Morselli M; Torelli G
Leukemia; 2004 Oct; 18(10):1572-5. PubMed ID: 15284857
[No Abstract] [Full Text] [Related]
45. Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation.
Ben-Ari Z; Mor E; Shaharabani E; Bar-Nathan N; Shapira Z; Tur-Kaspa R
Transplant Proc; 2000 Jun; 32(4):714-6. PubMed ID: 10856556
[No Abstract] [Full Text] [Related]
46. Partial splenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin.
Bárcena R; Gil-Grande L; Moreno J; Foruny JR; Otón E; García M; Blázquez J; Sánchez J; Moreno A; Moreno A
Transplantation; 2005 Jun; 79(11):1634-5. PubMed ID: 15940057
[No Abstract] [Full Text] [Related]
47. [Hepatitis C in childhood--natural history and therapy].
Nagata I; Murakami J; Okamoto M; Iitsuka T; Kanzaki S; Shiraki K
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):634-9. PubMed ID: 15359875
[No Abstract] [Full Text] [Related]
48. [International consensus conference on hepatitis C. Conclusions. Organized under the auspices of the European Association for the Study of the Liver (EASL)].
Ann Med Interne (Paris); 1999 Sep; 150(5):449-53. PubMed ID: 10544760
[No Abstract] [Full Text] [Related]
49. [Epidermolysis bullosa acquisita and hepatitis C].
Thiery S; Misery L; Chossegros P; Kanitakis J; Ghohestani R; Forestier JY; Trepo C; Faure M; Claudy A
Ann Dermatol Venereol; 1998 Apr; 125(4):264-7. PubMed ID: 9747265
[TBL] [Abstract][Full Text] [Related]
50. Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease.
Lethagen S; Widell A; Berntorp E; Verbaan H; Lindgren S
Br J Haematol; 2001 Apr; 113(1):87-93. PubMed ID: 11328286
[TBL] [Abstract][Full Text] [Related]
51. Hepatitis C treatment in patients on the liver transplant waiting list.
Verna EC; O'Leary JG
Curr Opin Organ Transplant; 2015 Jun; 20(3):242-50. PubMed ID: 25944239
[TBL] [Abstract][Full Text] [Related]
52. Long-term ribavirin therapy for recurrent hepatitis C after liver transplantation.
Aljumah AA; Cattral MS; Greig PD; Wanless IR; Krajden M; Hemming AW; Lilly LB; Levy GA
Transplant Proc; 1997; 29(1-2):514. PubMed ID: 9123110
[No Abstract] [Full Text] [Related]
53. Focus.
Samuel D
J Hepatol; 2010 Jan; 52(1):3-4. PubMed ID: 19923033
[No Abstract] [Full Text] [Related]
54. [Hepatic transplantation and HBV reinfection].
Xu X; Lu Z
Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):75-6. PubMed ID: 11856518
[No Abstract] [Full Text] [Related]
55. Hepatitis C in the pediatric population: transmission, natural history, treatment and liver transplantation.
Khaderi S; Shepherd R; Goss JA; Leung DH
World J Gastroenterol; 2014 Aug; 20(32):11281-6. PubMed ID: 25170212
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen.
Gambato M; Pérez-Del-Pulgar S; Hedskog C; Svarovskia ES; Brainard D; Denning J; Curry MP; Charlton M; Caro-Pérez N; Londoño MC; Koutsoudakis G; Forns X
Gastroenterology; 2016 Oct; 151(4):633-636.e3. PubMed ID: 27373513
[TBL] [Abstract][Full Text] [Related]
57. Hepatic hepatitis C virus RNA in chronic hepatitis C.
Craxì A; Di Marco V; Almasio PL
Ann Intern Med; 1996 Jan; 124(1 Pt 1):72. PubMed ID: 7503483
[No Abstract] [Full Text] [Related]
58. Is early antiviral therapy for recurrent hepatitis C after liver transplantation superior to later treatment? The answer is no.
Roche B; Samuel D
Liver Transpl; 2011 May; 17(5):488-91. PubMed ID: 21455930
[No Abstract] [Full Text] [Related]
59. [Structure and replication of viral hepatitis C virus, the key of the future therapeutic goals].
Grigorescu O; Luca CM; Moraru E
Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):877-81. PubMed ID: 20209756
[TBL] [Abstract][Full Text] [Related]
60. [Half of the patients respond to interferon treatment. Combination therapy is an alternative in chronic hepatitis C].
Weiland O; Norkrans G; Frydén A; Braconier JH
Lakartidningen; 1995 May; 92(18):1920-2. PubMed ID: 7746045
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
